Suppr超能文献

对Krev相互作用捕获蛋白1的非催化赖氨酸进行靶向可逆共价修饰,可实现蛋白质-蛋白质相互作用抑制剂的定点筛选。

Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein-Protein Interaction Inhibitors.

作者信息

Francisco Karol R, Bruystens Jessica, Varricchio Carmine, McCurdy Sara, Wu Jian, Lopez-Ramirez Miguel A, Ginsberg Mark, Caffrey Conor R, Brancale Andrea, Gingras Alexandre R, Hixon Mark S, Ballatore Carlo

机构信息

Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.

出版信息

ACS Pharmacol Transl Sci. 2023 Oct 9;6(11):1651-1658. doi: 10.1021/acsptsci.3c00156. eCollection 2023 Nov 10.

Abstract

The covalent reversible modification of proteins is a validated strategy for the development of probes and candidate therapeutics. However, the covalent reversible targeting of noncatalytic lysines is particularly challenging. Herein, we characterize the 2-hydroxy-1-naphthaldehyde (HNA) fragment as a targeted covalent reversible ligand of a noncatalytic lysine (Lys) of the Krev interaction trapped 1 (KRIT1) protein. We show that the interaction of HNA with KRIT1 is highly specific, results in prolonged residence time of >8 h, and inhibits the Heart of glass 1 (HEG1)-KRIT1 protein-protein interaction (PPI). Screening of HNA derivatives identified analogs exhibiting similar binding modes as the parent fragment but faster target engagement and stronger inhibition activity. These results demonstrate that HNA is an efficient site-directing fragment with promise in developing HEG1-KRIT1 PPI inhibitors. Further, the aldimine chemistry, when coupled with templating effects that promote proximity, can produce a long-lasting reversible covalent modification of noncatalytic lysines.

摘要

蛋白质的共价可逆修饰是开发探针和候选治疗药物的一种有效策略。然而,对非催化赖氨酸进行共价可逆靶向尤其具有挑战性。在此,我们将2-羟基-1-萘甲醛(HNA)片段表征为Krev相互作用捕获蛋白1(KRIT1)的非催化赖氨酸(Lys)的靶向共价可逆配体。我们表明,HNA与KRIT1的相互作用具有高度特异性,导致>8小时的延长驻留时间,并抑制玻璃之心1(HEG1)-KRIT1蛋白质-蛋白质相互作用(PPI)。对HNA衍生物的筛选确定了与母体片段具有相似结合模式但靶向结合更快且抑制活性更强的类似物。这些结果表明,HNA是一种有效的位点导向片段,有望用于开发HEG1-KRIT1 PPI抑制剂。此外,醛亚胺化学与促进邻近性的模板效应相结合时,可以产生对非催化赖氨酸的持久可逆共价修饰。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13fd/10644391/431680c81f10/pt3c00156_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验